Tuberculosis Associated with Infliximab, a TNF–Neutralizing Agent – (10-18-01)

Tuberculosis Associated with Infliximab, a TNF–Neutralizing Agent

It’s always interesting to see articles come out in different journals that all seem to revolve around a common theme. In this case, we see that the new “wonder drug” for Crohn’s and RA may have some severe side effects. I could accept these side effects in some patient if there were no alternative. However, with many autoimmune diseases, there are many options such as elimination diets, fasting and oral tolerance that can help control the disease.

NEJM — Abstracts: Keane et al. 345 (15): 1098

Read entire article here

For more than a decade, Dr. Bogash has stayed current with the medical literature as it relates to physiology, disease prevention and disease management. He uses his knowledge to educate patients, the community and cyberspace on the best way to avoid and / or manage chronic diseases using lifestyle and targeted supplementation.

Sign up for Dr. Bogash
Sign up for Dr. Bogash’s Rantings and instantly receive a free copy of his ebook “Dr. Bogash’s Recommendations for Healthy Living”

Email: